Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  Google Scholar 

Thomassen I, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134(3):622–8.

Article  CAS  Google Scholar 

Ajani JA, et al. Gastric cancer, version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(10):1286–312.

Article  Google Scholar 

Fujimoto S, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer. 1997;79(5):884–91.

Article  CAS  Google Scholar 

Yonemura Y, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 1996;119(4):437–44.

Article  CAS  Google Scholar 

Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review. J Gastrointest Oncol. 2021;12(Suppl 1):S5-17.

Article  Google Scholar 

Ellison LM, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis. Chin J Cancer Res. 2017;29(1):86–92.

Article  CAS  Google Scholar 

Desiderio J, et al. The 30-year experience: a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer. 2017;79:1–14.

Article  Google Scholar 

Wu Y, et al. Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis. BMC Surg. 2022;22(1):342.

Article  CAS  Google Scholar 

Deng H, Li B, Qin X. The short- and long-term survival of hyperthermic intraperitoneal chemotherapy (HIPEC) in the advanced gastric cancer with/without peritoneal carcinomatosis: a systematic review and meta-analysis of randomized controlled trials. Updates Surg. 2022;74(6):1805–16.

Article  Google Scholar 

Liu YW, Du Y, Chen BA. Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials. J Int Med Res. 2019;47(12):5926–36.

Article  Google Scholar 

Schunemann HJ, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ. 2003;169(7):677–80.

Google Scholar 

GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime, 2022. Available at gradepro.org.

Review Manager (RevMan) [Computer program]. Version 5.4, The Cochrane Collaboration, 2020.

Kuramoto M, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250(2):242–6.

Article  Google Scholar 

Yang XJ, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–81.

Article  Google Scholar 

Cui HB, et al. Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer. Exp Ther Med. 2014;7(5):1083–8.

Article  CAS  Google Scholar 

Kwon OK, Chung HY, Yu W. Early postoperative intraperitoneal chemotherapy for macroscopically serosa-invading gastric cancer patients. Cancer Res Treat. 2014;46(3):270–9.

Article  Google Scholar 

Rudloff U, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110(3):275–84.

Article  Google Scholar 

Huang O, et al. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up. Cell Biochem Biophys. 2015;71(2):1171–80.

Article  CAS  Google Scholar 

Lu C, et al. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites. Neoplasma. 2016;63(2):299–303.

CAS  Google Scholar 

Reutovich MY, Krasko OV, Sukonko OG. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. Eur J Surg Oncol. 2019;45(12):2405–11.

Article  Google Scholar 

Beeharry MK, et al. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer. 2019;19(1):932.

Article  CAS  Google Scholar 

Xie TY, et al. Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World J Gastrointest Oncol. 2020;12(7):782–90.

Article  Google Scholar 

Fan B, et al. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer. 2021;21(1):216.

Article  CAS  Google Scholar 

Liu L, et al. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer. Int J Hyperth. 2022;39(1):239–45.

Article  CAS  Google Scholar 

Bonnot PE, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37(23):2028–40.

Article  CAS  Google Scholar 

Brenkman HJF, et al. Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer-a systematic review. J Clin Med. 2019;8(10):1685.

Article  CAS  Google Scholar 

Koga S, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61(2):232–7.

Article  CAS  Google Scholar 

Hongjie Z, et al. Clinical observation of intraoperative hyperthermic intraperitoneal chemotherapy in 60 cases of advanced gastric cancer. Chin J Clin Oncol. 2010;37(04):229–31.

Google Scholar 

Guo M. Research on clinical effects of laparoscopic D2 radical gastrectomy and intraperitoneal hyperthermic chemotherapy for gastric cancer. J Laparosc Surg. 2017;22(01):42–5.

Google Scholar 

Allievi N, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Updates Surg. 2023;75(1):159–67.

Article  Google Scholar 

Zhentian N, et al. Meta-analysis of the efficacy and safety of surgery combined with intraoperative intraperitoneal hyperthermic chemotherapy in the treatment of advanced gastric cancer. Chin J Gastrointest Surg. 2016;19(12):1406–13.

Google Scholar 

Huang JY, et al. Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2012;13(9):4379–85.

Article  Google Scholar 

Mi DH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperth. 2013;29(2):156–67.

Article  CAS  Google Scholar